The Health Policy Association held a meeting of directors and supervisors on the 19th and invited Inventec Group Chairman Ye Guoyi, Fubon Financial Holdings Chairman Tsai Ming-hsing, and Taishin Financial Holdings Chairman Wu Dongliang to serve as consultants to the association. The three are senior figures in the financial and technology circles. They are expected to promote cross-domain cooperation among industry players in this field and bring funds to the major biomedical industry.
Yang Panchi, Vice Chairman of the Health Policy Council, issued a letter of appointment to Wu Dongliang, Chairman of Taishin Financial Holdings
The top 5 companies in the technology industry have been deploying smart medical care for a long time. Ye Guoyi himself pays great attention to the promotion of the medical field, mainly through the group's subsidiary Inventec Appliances. Ye Guoyi himself is a highly recommended senior figure in the technology industry. He is even respected by the founder of Electronic 5 Brother. He has a deep connection with Quanta. He was once the largest financial backer when Lin Baili started his business. He contributed money and efforts to help arrange financial connections. Because of Ye Guoyi's vision, Quanta later became the king of stocks, making Ye Guoyi rich.
Ye Guoyi is very concerned about health and medical care. Although he is no longer responsible for daily operations as the president, he still personally looks after the investment in medical projects. Inventec Appliances previously cooperated with Good Future to develop the "IronMag®circulating tumor cells automated detection system" for liquid slices, and simultaneously invested in smart medical related services and equipment layout; in addition, Inventec Appliances also developed Family Pal smart home testing equipment, smart pump infusion machines and other smart equipment. The investment in the former will reach the loss-even point this year.
Inventec Group Chairman Ye Guoyi (fourth from right), Inventec Appliances Chairman Zhang Jingsong (first from left) took a group photo with the Good Future team.
It is understood that Ye Guoyi is very concerned about smart medicine, precision medicine, and precision health. At yesterday's meeting, he also called on the government to relax regulations in the field of medical materials, otherwise it will be detrimental to internationalization. For example, the IronMag®circulating tumor cells automated testing system does not have FDA approval in Taiwan, but Chinese hospitals are very interested and have already placed orders for thousands of units.
The Health Policy Council invited Ye Guoyi to serve as the consultant of the Health Policy Council this time, and also specially arranged for Lin Baili to present a letter of appointment. The two took a photo together again after many years, and the meaning was particularly different.
Inventec Appliances, a subsidiary of Inventec Group, has developed circulating tumor cells automatic testing system. Ye Guoyi believes that Taiwan should relax its medical materials laws. Taiwan can only be used in medical centers, and many testing equipment cannot be exported without the FDA.
Taishin Gold is also very active in the field of medical technology. Chairman Wu Dongliang revealed at the meeting that it has recently completed a private equity fund of 1.5 billion yuan, and will also cooperate with Baorui Pharmaceutical to participate in international pharmaceutical mergers and acquisitions with 1.5 billion yuan. He also revealed that Taishin Financial is promoting the "Richard Life" financial ecosystem, hoping to include health, medical and precision medicine management platforms.
The two vice presidents Lin Baili and Yang Panchi awarded certificates to Ye Guoyi and Wu Dongliang respectively on the 19th. Cai Mingxing was busy and did not attend.
The two vice presidents Lin Baili and Yang Panchi awarded certificates to Ye Guoyi and Wu Dongliang respectively on the 19th. Cai Mingxing was busy and did not attend.
The Board of Directors re-elected directors and supervisors in 2019, inviting big names in the technology and electronics industry to join for the first time, and began to promote exchanges between the two industries to seize opportunities. In addition to the development of new biomedical drugs, it also actively promoted precision medicine, smart medicine, telemedicine and other application fields that combine digital technology and medical professions. 35 scientists The event included Quanta Chairman Lin Baili, Wistron Chairman Lin Xianming, Pegatron Chairman Tong Zixian, Catcher Chairman Hong Shushu, Qisda Chairman Chen Qihong, Realtek Chairman Ye Boren, Advantech Chairman Liu Kezhen, Chongyue Chairman Guo Zhihui, and iKala Director Jian Lifeng all joined.
Source----
"Digital Age"
